New pill may help cancer patients avoid chemo delays due to low platelets

This study tests a daily pill called hetrombopag to see if it can safely raise low platelet counts in women with gynecological cancers (like ovarian or cervical cancer) after chemotherapy. About 244 women whose platelets dropped too low will take the drug to help them complete their next chemo cycle on time and at full dose. The goal is to reduce the need for platelet transfusions and keep cancer treatment on track.